Johannes N van den Anker (Johannes van den Anker, John N van den Anker, John van den Anker)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 8

Top Topics

Low Birth Weight

Emergency Department

Top Venues

British journal of clinical pharmacology

Clinical pharmacokinetics

Journal of pharmacokinetics and pharmacodynamics

Journal of thrombosis and haemostasis : JTH

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Drozdov, Gabriel Konetzny, Philipp Meyer, Johannes N van den Anker, Sara Bernhard, Nicole Ritz
Dosing and Monitoring of Isoniazid in a Preterm, Extremely Low Birth Weight Infant After In Utero Exposure to Mycobacterium tuberculosis: A Case Study and Literature Review. The Pediatric infectious disease journal 41 (12) (2022)
Adam Miszta, Homa Khorrami Ahmadzia, Naomi L C Luban, Shuhui Li, Dong Guo, Lori A Holle, Jeffrey S Berger, Andra H James, Jogarao V S Gobburu, Johannes N van den Anker, Bas de Laat, Alisa S Wolberg
Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery. Journal of thrombosis and haemostasis : JTH 19 (1) (2020)
Jamil M Kazma, Johannes N van den Anker, Karel Allegaert, Andre Dallmann, Homa Khorrami Ahmadzia
Anatomical and physiological alterations of pregnancy. Journal of pharmacokinetics and pharmacodynamics 47 (4) (2020)
Cornelis Smit, Mariska Y M Peeters, Johannes N van den Anker, Catherijne A J Knibbe
Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties. Clinical pharmacokinetics 59 (6) (2020)
Tatjana Welzel, Victoria C Ziesenitz, Peter Weber, Alexandre N Datta, Johannes N van den Anker, Verena Gotta
Drug-drug and drug-food interactions in an infant with early-onset SCN2A epilepsy treated with carbamazepine, phenytoin and a ketogenic diet. British journal of clinical pharmacology 87 (3) (2020)
Victoria C Ziesenitz, Janelle D Vaughns, Gilbert Koch, Gerd Mikus, Johannes N van den Anker
Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review. Clinical pharmacokinetics 57 (2) (2019)
Philip Lambrechtse, Victoria C Ziesenitz, Adam A Cohen, Johannes N van den Anker, Ernst Jan Bos
How reliable are commercially available trackers in detecting daytime sleep. British journal of clinical pharmacology 84 (3) (2018)
Victoria C Ziesenitz, Andreas Zutter, Thomas O Erb, Johannes N van den Anker
Efficacy and Safety of Ibuprofen in Infants Aged Between 3 and 6 Months. Paediatric drugs 19 (4) (2017)